Product NDC: | 66312-540 |
Proprietary Name: | Citanest Forte |
Non Proprietary Name: | prilocaine hydrochloride and epinephrine bitartrate |
Active Ingredient(s): | .005; 40 mg/mL; mg/mL & nbsp; prilocaine hydrochloride and epinephrine bitartrate |
Administration Route(s): | DENTAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66312-540 |
Labeler Name: | Dentsply Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021383 |
Marketing Category: | NDA |
Start Marketing Date: | 19651118 |
Package NDC: | 66312-540-16 |
Package Description: | 50 CARTRIDGE in 1 CARTON (66312-540-16) > 1.7 mL in 1 CARTRIDGE |
NDC Code | 66312-540-16 |
Proprietary Name | Citanest Forte |
Package Description | 50 CARTRIDGE in 1 CARTON (66312-540-16) > 1.7 mL in 1 CARTRIDGE |
Product NDC | 66312-540 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | prilocaine hydrochloride and epinephrine bitartrate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | DENTAL |
Start Marketing Date | 19651118 |
Marketing Category Name | NDA |
Labeler Name | Dentsply Pharmaceutical Inc. |
Substance Name | EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE |
Strength Number | .005; 40 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |